TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
ARTV

Artiva Biotherapeutics, Inc.

Healthcare · Biotechnology

7.50$ -3.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Artiva Biotherapeutics, Inc. (ARTV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 369 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARTV
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 105 90 76 226 210 191 169 149 131 106 369
– 80 66 50 151 189 170 149 130 113 89 352
– 54 48 34 56 40 30 28 26 27 21 301
– 77 62 47 147 185 166 142 123 108 87 349
– 1.8 1.7 1.5 0.7 0.1 1.0 0.0 0.9 0.8 0.6 0.1
– 267 265 267 25 23 22 20 20 21 18 21
– 12 10 11 13 12 12 11 11 13 11 15
– 3.6 3.6 3.8 3.7 3.7 3.7 3.6 3.2 3.1 3.0 3.3
– 0.6 1.5 0.8 1.2 1.1 2.0 1.2 0.8 0.4 2.3 1.4
– -162 -175 -191 201 187 169 149 129 110 88 348
– -181 -195 -213 -231 -247 -267 -288 -310 -331 -354 -379
19 20 18 23 24 24 24 24 24 24 25 39

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?